spacer gif spacer gif spacer gif spacer gif Propose a workshop for 2011 spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search    

The fully linked HTML version of this article has now been published.
JCS ePress online publication date 9 Nov 2004
doi: 10.1242/jcs.01418


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcs.01418v1
117/25/5975    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crane, R.
Right arrow Articles by Ruderman, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crane, R.
Right arrow Articles by Ruderman, J. V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Research Article

Requirements for the destruction of human Aurora-A


Richard Crane, Angela Kloepfer, and Joan V. Ruderman*
* Author for correspondence (e-mail: ruderman{at}hms.harvard.edu)

The mitotic kinase Aurora A (Aur-A) is overexpressed in a high proportion of human tumors, often in the absence of gene amplification. In somatic cells, Aur-A protein levels fall following mitosis or upon overexpression of Cdh1, an activator of the ubiquitin ligase APC/C. Thus, mutations that reduce or block the rate of Aur-A destruction might also be expected to contribute to its oncogenic potential. Previous work had defined two short sequences of Xenopus Aur-A that are required for its Cdh1-inducible destruction in extracts of Xenopus eggs, an N-terminal A box and a C-terminal D box, and a serine residue within the A box whose phosphorylation might inhibit destruction. Here, we show that these same sequences are required for the destruction of human Aur-A during mitotic exit and G1 in the somatic cell cycle. Expression of a dominant negative Cdh1 protein leads to accumulation of Aur-A, further indicating that the Cdh1-activated form of the APC/C is responsible for destruction of Aur-A during the somatic cell cycle in vivo. During the course of this work, we found some previously unsuspected problems in commonly used in vitro destruction assays, which can result in misleading results. Potentially confounding factors include: (i) the presence of D-box- and A-box-dependent destruction-promoting activities in the reticulocyte in vitro translation mix that is used to produce radiolabeled substrates for destruction assays; and (ii) the ability of green-fluorescent-protein tags to reduce the destruction rate of Aur-A substantially. These findings have direct relevance for studies of Aur-A destruction itself, and for broader approaches that use in vitro translation products in screens for additional APC/C targets.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
M. A. Hardwicke, C. A. Oleykowski, R. Plant, J. Wang, Q. Liao, K. Moss, K. Newlander, J. L. Adams, D. Dhanak, J. Yang, et al.
GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models
Mol. Cancer Ther., July 1, 2009; 8(7): 1808 - 1817.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
C. Man, J. Rosa, Y. L. Yip, A. L.-M. Cheung, Y. L. Kwong, S. J. Doxsey, and S. W. Tsao
Id1 Overexpression Induces Tetraploidization and Multiple Abnormal Mitotic Phenotypes by Modulating Aurora A
Mol. Biol. Cell, June 1, 2008; 19(6): 2389 - 2401.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. Fu, M. Bian, Q. Jiang, and C. Zhang
Roles of Aurora Kinases in Mitosis and Tumorigenesis
Mol. Cancer Res., January 1, 2007; 5(1): 1 - 10.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. S. Udayakumar, M. Belakavadi, K.-H. Choi, P. K. Pandey, and J. D. Fondell
Regulation of Aurora-A Kinase Gene Expression via GABP Recruitment of TRAP220/MED1
J. Biol. Chem., May 26, 2006; 281(21): 14691 - 14699.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. S. Stanford and J. V. Ruderman
Changes in Regulatory Phosphorylation of Cdc25C Ser287 and Wee1 Ser549 during Normal Cell Cycle Progression and Checkpoint Arrests
Mol. Biol. Cell, December 1, 2005; 16(12): 5749 - 5760.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Stewart and G. Fang
Destruction Box-Dependent Degradation of Aurora B Is Mediated by the Anaphase-Promoting Complex/Cyclosome and Cdh1
Cancer Res., October 1, 2005; 65(19): 8730 - 8735.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Fukuda, Y. Mishina, M. P. Walker, and R. P. DiAugustine
Conditional Transgenic System for Mouse Aurora A Kinase: Degradation by the Ubiquitin Proteasome Pathway Controls the Level of the Transgenic Protein
Mol. Cell. Biol., June 15, 2005; 25(12): 5270 - 5281.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2004